Trials is inviting submission of manuscripts, long and short, including original research, letters and commentaries relating to the use of electronic consent (e-Consent) in clinical trials. Whilst e-Consent was permitted from a regulatory and ethical perspective previously, its use has increased more recently, not least due to the Covid-19 pandemic and the need to move some clinical trial processes remotely. Whilst there may be benefits to implementing e-Consent, it is not without challenges and as more people engage in implementing e-Consent, Trials is keen to share trialists’ experiences, innovations, case studies and methodological research into this emerging area.
Submission Status: Open | Submission Deadline: 31 December 2023